SCHEMBL21177688

SCHEMBL21177688

COCc1nc(Cl)cc(N(C)C)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
TUBB4A P04350 1/20 0.37
TUBB P07437 1/20 0.37
TUBA3C P0DPH7 1/20 0.37
TUBA1B P68363 1/20 0.37
TUBA4A P68366 1/20 0.37
TUBB4B P68371 1/20 0.37
TUBB3 Q13509 1/20 0.37
TUBB2A Q13885 1/20 0.37
TUBB8 Q3ZCM7 1/20 0.37
TUBA3E Q6PEY2 1/20 0.37
TUBA1A Q71U36 1/20 0.37
TUBA1C Q9BQE3 1/20 0.37
TUBB6 Q9BUF5 1/20 0.37
TUBB2B Q9BVA1 1/20 0.37
TUBB1 Q9H4B7 1/20 0.37
KDM4E B2RXH2 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.33
POLB P06746 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20906057 0.88 KDM4E (0.38) KMT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL3878733 0.82 S1PR4 (0.33) KMT2ATUBB4ATUBBTUBA3CTUBA1B
SCHEMBL8168620 0.81 KMT2A (0.44) KMT2AMEN1KDM4ESMN1; SMN2POLB
SCHEMBL2534992 0.79 KMT2A (0.42) KMT2AMEN1KDM4ESMN1; SMN2POLB
SCHEMBL18614528 0.76 HTT (0.41) KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL4595504 0.74 SMN1; SMN2 (0.37) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL17581161 0.74 MAPT (0.38) KMT2AMEN1KDM4ESMN1; SMN2POLB
SCHEMBL13501522 0.74 HCAR2 (0.33) KMT2AMEN1
SCHEMBL4596233 0.73 ALDH1A1 (0.33) SMN1; SMN2
SCHEMBL10995423 0.72 KMT2A (0.37) KMT2AMEN1KDM4ESMN1; SMN2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019141957-A1 N-PYRIMIDINYL HYDROXY PYRAZOLE DERIVATIVES AND USES THEREOF CADO BIOTECHNOLOGY IVS (DK) 2019-07-25 WO disclosed